首页> 外文期刊>Indian Journal of Pharmaceutical Education & Research >Preparation and Evaluation of Self-nanoemulsifying Formulation of Efavirenz
【24h】

Preparation and Evaluation of Self-nanoemulsifying Formulation of Efavirenz

机译:依非韦伦自纳米乳化制剂的制备与评价

获取原文
获取原文并翻译 | 示例
       

摘要

Efavirenz is an antiretroviral drug which exhibits lower absorption in gastric fluid due to poor water solubility characteristics. Self-nanoemulsifying drug delivery systems (SNEDDS) were designed with the objective of improving the solubility and dissolution rate of the drug. Solubility of efavirenz was determined in various vehicles, which includes oils (/modified oils), surfactants and co-surfactants. Pseudo-ternary phase diagrams were constructed to identify the most efficient self-emulsification region. Based on the solubility labrafac PG(oil), tween 80 (surfactant), PEG 200 (Cosurfactant) were selected for preparation of SNEDDS. FTIR spectroscopy was performed in order to investigate the interaction between any of the ingredients used in the formulation. The prepared formulations were evaluated for thermodynamic stability (centrifugation, heating cooling cycle (H/C cycle), freeze thaw cycle), dispersibility, robustness to dilution, particle size measurements, zeta potential, refractive index, percent transmittance, viscosity, drug content and In vitro drug release. The FTIR data confirms that there is no interaction between the drug and the excipients. The optimized efavirenz SNEDDS contains labrafac PG(15%), Tween 80(19%) and PEG 200(38%) which shows mean globule size of 142.8 nm. In i///ro drug release of the formulation was found to be 97.4 % in 20min whereas pure drug shows only 22.4% at the end of 30 min. The stability study of prepared SNEDDS shows same physicochemical properties as compare to initial SNEDDS after 3 month storing in stability chamber at 40deg 'C and 75%RH.
机译:依非韦伦是一种抗逆转录病毒药物,由于水溶性差,在胃液中的吸收较低。设计了自纳米乳化药物递送系统(SNEDDS),目的是提高药物的溶解度和溶解速率。依法韦仑的溶解度在各种媒介物中测定,包括油(/改性油),表面活性剂和助表面活性剂。伪三元相图可以识别最有效的自乳化区域。基于溶解度的拉布拉夫PG(油),选择吐温80(表面活性剂),PEG 200(辅助表面活性剂)来制备SNEDDS。进行FTIR光谱分析是为了研究配方中所用任何成分之间的相互作用。评价制备的制剂的热力学稳定性(离心,加热冷却循环(H / C循环),冻融循环),分散性,稀释稳定性,粒度测量,ζ电势,折射率,透光率,粘度,药物含量和体外药物释放。 FTIR数据证实了药物与赋形剂之间没有相互作用。优化的依非韦伦SNEDDS包含拉拉巴夫PG(15%),吐温80(19%)和PEG 200(38%),其平均小球尺寸为142.8 nm。在20分钟内,发现该制剂的药物释放为97.4%,而纯药物在30分钟结束时仅显示22.4%。制备的SNEDDS的稳定性研究表明,与初始SNEDDS相比,在40℃和75%RH的稳定室内储存3个月后,其理化性质与初始SNEDDS相同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号